Thia Ventures

Thia Ventures, founded in 2021 and based in Geneva, Switzerland, is a venture capital firm that focuses on early-stage investments. The firm targets seed-stage and early-stage companies in the nutrition, healthcare, and biotechnology sectors, which are recognized as dynamic and essential fields of contemporary human endeavor. By concentrating on these areas, Thia Ventures aims to support innovative solutions that address critical challenges in health and well-being.

Abel Rossignol

Partner

Adrien Tardy

Partner

19 past transactions

UFraction8

Venture Round in 2025
uFraction8 specializes in scalable bioprocessing technology that enhances biomass filtration, separation, and dewatering. The company's innovative approach utilizes microfluidic devices to efficiently process a wide range of microbes, including microalgae, yeast, and bacteria. Unlike traditional methods such as centrifuges, filters, and membranes, uFraction8's technology sorts biomass from culture media without causing harm and without the use of flocculants. This advanced cell separation technology enables industries to achieve higher throughput and reduce costs compared to conventional liquid processing methods. By focusing on industrial-scale applications, uFraction8 provides solutions that streamline operations in various sectors while maintaining efficiency and effectiveness.

Switch Bioworks

Seed Round in 2024
Switch Bioworks is a biofertilizer company that focuses on creating sustainable nitrogen fertilizers by genetically reprogramming naturally occurring symbiotic microbes. These engineered microbes function as controlled fertilizer-producing mini-factories located at the roots of plants. This innovative approach provides farmers with a cost-effective and environmentally friendly alternative to traditional chemical nitrogen fertilizers, enhancing agricultural productivity while minimizing ecological impact.

EvodiaBio

Series A in 2024
EvodiaBio is a bio-industrial company based in Copenhagen that specializes in the development of natural and sustainable aromas for the food and beverage industries. Founded in 2021, the firm focuses on creating yeast-based products that serve as natural substitutes for traditional ingredients such as fresh hops, pellets, and hop oil. This innovation allows breweries to produce non-alcoholic beer without sacrificing flavor, thereby addressing the growing demand for high-quality, alcohol-free options in the beverage market.

Protealis

Series B in 2024
Protealis specializes in developing advanced seeds and seed technologies for legume crops, focusing on enhancing their adaptability to the European environment. The company aims to become a leading provider of germplasm for sustainable plant proteins, leveraging innovative breeding techniques and nitrogen fixation. By utilizing proprietary seed coatings and advanced breeding technologies, Protealis seeks to maximize the potential of legume crops. This approach not only helps farmers address protein deficits but also supports local sourcing for the increasing demand from producers of meat and milk alternatives.

Clever Carnivore

Seed Round in 2023
Clever Carnivore is a Chicago-based cultivated meat company founded in 2021 by Dr. Paul Burridge and Dr. Virginia Rangos. The company focuses on creating sustainable and cost-competitive cultivated meat products, primarily pork, using optimized cell lines and bioprocesses. By leveraging biotechnology, Clever Carnivore aims to offer accessible and delicious meat alternatives that cater to the increasing global demand for food while promoting ethical consumption. Currently, the company is developing a range of pork products, including bratwurst, breakfast sausage, and Italian-style meatballs, in preparation for its upcoming fundraising efforts.

Pow.bio

Series A in 2023
Pow.bio specializes in intelligent fermentation services tailored for industrial and synthetic biology applications. The company aims to transform innovative ideas into profitable products by utilizing continuous fermentation combined with advanced control methodologies. This approach allows Pow.bio to optimize fermentation processes rapidly, resulting in high yields at reduced costs. Their fermentation capabilities range from 1 to 100 liters, accommodating various microorganisms, including bacteria, yeast, and filamentous fungi. By addressing the capacity challenges in fermentation, Pow.bio seeks to empower scientists to develop sustainable alternatives that can compete with traditional, less sustainable practices.

Allozymes

Series A in 2023
Allozymes is a deep technology company that specializes in ultrahigh-throughput microfluidics technology to enhance enzyme evolution and development. It focuses on creating sensitive and accurate assays for enzymatic reactions, alongside proprietary microfluidic chips and proteomics technologies. By employing molecular biology and process engineering, Allozymes aims to produce pure enzymes tailored for specific applications. This innovative platform enables clients to expedite custom enzyme development and to create novel, sustainable natural products.

Chromologics

Seed Round in 2023
Chromologics is a Danish biotechnology company that specializes in the development of innovative natural food colorants. Originating as a spin-out from the Technical University of Denmark, the company utilizes a fermentation-derived platform to produce novel, sustainable color pigments. These colorants are designed to be stable across various pH levels and temperatures, making them suitable for a wide range of food applications. By offering a bio-based alternative to traditional colorants like carmine, Chromologics aims to support food producers in creating more natural products while enhancing the color of their offerings.

People Science

Seed Round in 2023
People Science is a technology-driven research and development platform focused on alternative medicine. The company facilitates connections between health-conscious individuals, medical professionals, and research scientists while supporting manufacturers in creating products grounded in scientific testing. By providing a scaled research platform, People Science enables customers to identify alternative medicines that may aid in their wellness journeys, ensuring that these solutions are backed by rigorous research and evidence.

Liberation Labs

Seed Round in 2022
Liberation Labs is a biotechnology firm specializing in industrial agricultural biotechnology systems aimed at addressing the fermentation capacity gap in cellular agriculture. The company focuses on developing infrastructure that enables the commercialization of novel protein manufacturing at scale and competitive cost structures. By doing so, it supports biology innovators in their efforts to compete with traditional animal protein sources while ensuring that customers have access to nutritious food options.

EvodiaBio

Seed Round in 2022
EvodiaBio is a bio-industrial company based in Copenhagen that specializes in the development of natural and sustainable aromas for the food and beverage industries. Founded in 2021, the firm focuses on creating yeast-based products that serve as natural substitutes for traditional ingredients such as fresh hops, pellets, and hop oil. This innovation allows breweries to produce non-alcoholic beer without sacrificing flavor, thereby addressing the growing demand for high-quality, alcohol-free options in the beverage market.

Synonym

Pre Seed Round in 2022
Synonym Biotechnologies is a financing and development platform focused on essential biomanufacturing infrastructure. Founded in 2021 and headquartered in New York, the company aims to enhance production capacity for synthetic biology firms by organizing key aspects such as site selection, engineering, and financing. Its platform facilitates access to biomanufacturing investments and project financing, enabling a diverse range of industry players to respond to the increasing demand for consumables like food, materials, and energy. By creating this new asset class, Synonym supports the growth of the bioeconomy and fosters innovation in biomanufacturing.

Gourmey

Series A in 2022
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

Core Biogenesis

Series A in 2022
Core Biogenesis is a biotechnology company based in Paris, France, established in 2020. It specializes in next-generation recombinant protein production technologies, utilizing proprietary gene editing and plant biotechnology to significantly lower the costs associated with producing growth factors. These growth factors are crucial for applications in the clean meat and cell therapy industries. The company has developed an ultra-scalable bioproduction platform that leverages plants as biofactories, enabling efficient mass production and targeted extraction of valuable bioproducts. This innovative approach not only accelerates production but also enhances the ability to regulate cell growth and increases yields, making it a valuable partner for clients in the healthcare sector.

Bond Pet Foods

Venture Round in 2022
Bond Pet Foods is a Boulder, Colorado-based company that specializes in creating sustainable pet food products using biotechnology. Founded in 2015, the company develops meat proteins derived from animal cells without the need for animal slaughter, and utilizes fermentation processes similar to those found in craft brewing. The proteins are cultivated in fermentation tanks and are supplemented with a nutrient-rich broth containing vitamins, sugars, and minerals, ensuring they meet the nutritional needs of companion animals. By offering all-natural and animal-free alternatives, Bond Pet Foods aims to provide environmentally friendly options for pet owners while supplying its innovative ingredients to pet food manufacturers for incorporation into their recipes and product lines.

Avant Meats

Venture Round in 2022
Avant Meats is a biotechnology company specializing in the production of cell-based animal protein products, particularly fish and marine proteins. The company has developed an innovative platform that allows for the creation of nutritious and flavorful fish proteins directly from fish cells, eliminating the need for traditional methods such as raising, catching, or slaughtering animals. This approach enables the sustainable cultivation of animal-free proteins in a controlled environment, ensuring that the products are free from pollutants. Avant Meats aims to provide consumers with sustainable protein options for food, skincare, and functional applications, while also focusing on technology, product innovation, and the development of a robust intellectual property portfolio.

Mori

Series B in 2022
Mori, formerly known as Overlook Research, is a company that develops a natural biopolymer coating designed to extend the shelf life of perishable foods. Founded in 2016 and headquartered in Boston, Massachusetts, Mori's innovative coating is made from proteins extracted from natural silk using salt and water. This protective layer helps slow the spoiling process of various food items, including fruits, vegetables, meat, and seafood, thereby reducing food waste. By focusing on sustainable and economical solutions, Mori aims to transform the food supply and enhance the efficiency of the food, agriculture, and packaging industries.

UFraction8

Seed Round in 2022
uFraction8 specializes in scalable bioprocessing technology that enhances biomass filtration, separation, and dewatering. The company's innovative approach utilizes microfluidic devices to efficiently process a wide range of microbes, including microalgae, yeast, and bacteria. Unlike traditional methods such as centrifuges, filters, and membranes, uFraction8's technology sorts biomass from culture media without causing harm and without the use of flocculants. This advanced cell separation technology enables industries to achieve higher throughput and reduce costs compared to conventional liquid processing methods. By focusing on industrial-scale applications, uFraction8 provides solutions that streamline operations in various sectors while maintaining efficiency and effectiveness.

Protealis

Series A in 2021
Protealis specializes in developing advanced seeds and seed technologies for legume crops, focusing on enhancing their adaptability to the European environment. The company aims to become a leading provider of germplasm for sustainable plant proteins, leveraging innovative breeding techniques and nitrogen fixation. By utilizing proprietary seed coatings and advanced breeding technologies, Protealis seeks to maximize the potential of legume crops. This approach not only helps farmers address protein deficits but also supports local sourcing for the increasing demand from producers of meat and milk alternatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.